Sign in

Cluster headache: diagnosis and treatment

Headache and orofacial pain · C7 · Reviewed by a board-certified pain physician on October 31, 2026

Bottom line

Cluster headache is severe unilateral orbital pain lasting 15–180 minutes with ipsilateral autonomic signs or restlessness; treat attacks with high-flow oxygen or a fast triptan, and use oxygen when triptans are contraindicated.

Key points

  1. ICHD-3 defines the attack. At least five attacks of severe unilateral orbital, supraorbital or temporal pain lasting 15–180 minutes untreated, with ipsilateral autonomic features and/or restlessness, from every other day to 8 a day. During the worst attacks pain is excruciating, and patients usually cannot lie down 1.
  2. Autonomic signs are ipsilateral. They include conjunctival injection or lacrimation, nasal congestion or rhinorrhea, eyelid edema, facial sweating, and miosis or ptosis 1.
  3. Bouts and remissions define the episodic form. Attacks cluster in periods of weeks or months, usually on the same side within a period, separated by remissions usually lasting months or years; 10–15% have chronic cluster headache without such remissions 1.
  4. Three acute treatments are Level A. The AHS guideline gives Level A to subcutaneous sumatriptan, zolmitriptan nasal spray and high-flow oxygen 2.
  5. Oxygen works fast. In a randomized crossover trial, 100% oxygen at 12 L/min by face mask for 15 minutes made 78% of attacks pain-free at 15 minutes versus 20% with air 3.
  6. Suboccipital steroid is the Level A preventive. Suboccipital steroid injection is the only preventive with a Level A recommendation in the 2016 AHS guideline 2.

Watch for

Sumatriptan is contraindicated with coronary artery disease or vasospasm, prior stroke or TIA, peripheral vascular disease and uncontrolled hypertension; high-flow oxygen is the Level A acute alternative without these cardiovascular limits 24.

High-yield for the exam

  • Subcutaneous sumatriptan for cluster headache is a single 6 mg dose; maximum 12 mg in 24 hours, at least 1 hour apart 4.
  • Sphenopalatine ganglion stimulation received a Level B recommendation for acute treatment 2.
  • Deep brain stimulation had a negative study (Level B); warfarin a positive study (Level C) 2.
  • Men are affected about three times as often as women, and onset is usually at age 20–40 1.
  • Acute attacks involve activation of the posterior hypothalamic gray matter 1.
  • About 5% of cluster headache may be autosomal dominant 1.
  • During a cluster period, attacks may be provoked by alcohol, histamine or nitroglycerin 1.

Numbers to know

Item Value
Attack duration (untreated) 15–180 minutes 1
Attack frequency every other day to 8/day 1
Minimum attacks for diagnosis 5 1
Oxygen regimen 100%, 12 L/min, 15 min 3
Pain-free at 15 min, oxygen vs air 78% vs 20% 3
Chronic cluster share 10–15% 1
Oxygen trial participants 57 episodic, 19 chronic 3
Typical age at onset 20–40 years 1

Common traps

  • Using low-flow oxygen; the trial used 100% oxygen at 12 L/min by face mask at attack onset 3.
  • Giving sumatriptan to a patient with coronary disease or recent ergot use 4.
  • Confusing cluster headache with paroxysmal hemicrania, whose attacks are shorter and indomethacin-responsive 5.

Practise this topic

1 more question on this topic in the full question bank, with explanations and sources.

Sources

  1. International Headache Society. ICHD-3: 3.1 Cluster headache. ichd-3.org, accessed 2026. ichd-3.org/3-trigeminal-autonomic-cephalalgias/3-1-cluster-h
  2. Robbins MS, et al. Treatment of cluster headache: the American Headache Society evidence-based guidelines. Headache, 2016. pubmed.ncbi.nlm.nih.gov/27432623/
  3. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA, 2009. pubmed.ncbi.nlm.nih.gov/19996400/
  4. US Food and Drug Administration. IMITREX (sumatriptan) injection prescribing information. DailyMed, 2026. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fee7d073-0b
  5. International Headache Society. ICHD-3: 3.2 Paroxysmal hemicrania. ichd-3.org, accessed 2026. ichd-3.org/3-trigeminal-autonomic-cephalalgias/3-2-paroxysma

Related topics

Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.